| Systematic (IUPAC) name | |
|---|---|
| isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Clinical data | |
| Trade names | Sular |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a696009 |
| Pregnancy cat. | C (US) |
| Legal status | ℞-only (US) |
| Routes | Oral |
| Pharmacokinetic data | |
| Protein binding | 99% |
| Half-life | 7-12 hours |
| Identifiers | |
| CAS number | 63675-72-9 |
| ATC code | C08CA07 |
| PubChem | CID 4499 |
| IUPHAR ligand | 2524 |
| DrugBank | DB00401 |
| ChemSpider | 4343 |
| UNII | 4I8HAB65SZ |
| KEGG | D00618 |
| ChEMBL | CHEMBL1726 |
| Chemical data | |
| Formula | C20H24N2O6 |
| Mol. mass | 388.414 g/mol |
| |
|
Nisoldipine (INN) is a calcium channel blocker of the dihydropyridine class. It sold in the United States under the proprietary name Sular. Nisoldipine has tropism for cardiac blood vessels. [1]
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)